Study shows risk for emergently treated hypocalcemia with denosumab rises with CKD stage
For patients with chronic kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases with ...
Medscape7 天
Denosumab Raises Hypocalcemia Risk in Chronic Kidney Disease
The risk for emergently treated hypocalcemia in individuals receiving denosumab peaked at 2 weeks after administration and ...
healthday on MSN9 天
Risk for Emergently Treated Hypocalcemia With Denosumab Rises With CKD Stage
For patients with chronic kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases ...
Daily3 天
Denosumab Linked to Higher Risk of Severe Hypocalcemia in Older Female Dialysis-Dependent ...
USA: A target trial emulation study revealed that denosumab significantly increased the risk of hypocalcemia requiring ...
rheumatologyadvisor3 天
Denosumab vs Bisphosphonate Use Ups Emergency Hypocalcemia Risk in Advanced CKD
Denosumab treatment for osteoporosis appears more hazardous in postmenopausal women with advanced chronic kidney disease (CKD).
2minutemedicine.com10 天
Denosumab increases risk of severe hypocalcemia in women with osteoporosis and chronic ...
In this target trial emulation study, denosumab was found to increase the risk of hypocalcemia requiring emergency treatment as compared with bisphosphonates among women with osteoporosis in the ...
IPM12 天
Should I Use Intravenous Calcium to Prevent Subclinical Hypocalcemia?
Hypocalcemia is an important postpartum metabolic disease. Although the use of anionic salts as a preventive strategy in prepartum diets has been widely implemented, hypocalcemia remains one of the ...